Collegium Pharmaceutical (354) Stock Statistics & Valuation Metrics
Total Valuation
Collegium Pharmaceutical has a market cap or net worth of EUR 691.46M. The enterprise value is EUR 2.24B.
- Market Cap
- EUR 691.46M
- Enterprise Value
- EUR 2.24B
Share Statistics
Collegium Pharmaceutical has 32,555,614 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 32,555,614
- Owned by Insiders
- 3.30%
- Owned by Institutions
- 66.98%
Financial Efficiency
Collegium Pharmaceutical’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 10.18%.
- Return on Equity (ROE)
- 0.21
- Return on Assets (ROA)
- 0.04
- Return on Invested Capital (ROIC)
- 10.18%
- Return on Capital Employed (ROCE)
- 0.15
- Revenue Per Employee
- 1.85M
- Profits Per Employee
- 148.63K
- Employee Count
- 423
- Asset Turnover
- 0.47
- Inventory Turnover
- 7.76
Valuation Ratios
The current PE Ratio of Collegium Pharmaceutical is 15.56. Collegium Pharmaceutical’s PEG ratio is 0.52.
- PE Ratio
- 15.56
- PS Ratio
- 0.96
- PB Ratio
- 2.48
- Price to FCF
- 2.36
- Price to Operating Cash Flow
- 2.34
- PEG Ratio
- 0.52
Income Statement
In the last 12 months, Collegium Pharmaceutical had revenue of 780.57M and earned 62.87M in profits. Earnings per share was 1.98.
- Revenue
- 780.57M
- Gross Profit
- 463.26M
- Operating Income
- 187.08M
- Pretax Income
- 92.62M
- Net Income
- 62.87M
- EBITDA
- 401.00M
- Earnings Per Share (EPS)
- 1.98
Cash Flow
In the last 12 months, operating cash flow was 329.92M and capital expenditures -1.64M, giving a free cash flow of 328.28M billion.
- Operating Cash Flow
- 329.92M
- Free Cash Flow
- 328.28M
- Free Cash Flow per Share
- 10.11
Dividends & Yields
Collegium Pharmaceutical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 42.37%
- Earnings Yield
- 6.20%
Stock Price Statistics
- Beta
- 0.75
- 52-Week Price Change
- -30.92%
- 50-Day Moving Average
- 20.24
- 200-Day Moving Average
- 28.27
- Relative Strength Index (RSI)
- 58.74
- Average Volume (3m)
- 70
Important Dates
Collegium Pharmaceutical upcoming earnings date is Nov 05, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 06, 2026
- Next Earnings Date
- Nov 05, 2026
- Ex-Dividend Date
- ―
Financial Position
Collegium Pharmaceutical as a current ratio of 1.57, with Debt / Equity ratio of 311.78%
- Current Ratio
- 1.57
- Quick Ratio
- 1.48
- Debt to Market Cap
- 0.64
- Net Debt to EBITDA
- 1.72
- Interest Coverage Ratio
- 2.27
Taxes
In the past 12 months, Collegium Pharmaceutical has paid 29.75M in taxes.
- Income Tax
- 29.75M
- Effective Tax Rate
- 0.32
Enterprise Valuation
Collegium Pharmaceutical EV to EBITDA ratio is 3.18, with an EV/FCF ratio of 4.58.
- EV to Sales
- 1.86
- EV to EBITDA
- 3.18
- EV to Free Cash Flow
- 4.58
- EV to Operating Cash Flow
- 4.56
Balance Sheet
Collegium Pharmaceutical has EUR 129.47M in cash and marketable securities with EUR 857.79M in debt, giving a net cash position of -EUR 728.33M billion.
- Cash & Marketable Securities
- EUR 129.47M
- Total Debt
- EUR 857.79M
- Net Cash
- -EUR 728.33M
- Net Cash Per Share
- -EUR 22.37
- Tangible Book Value Per Share
- -EUR 32.79
Margins
Gross margin is 60.02%, with operating margin of 19.61%, and net profit margin of 5.93%.
- Gross Margin
- 60.02%
- Operating Margin
- 19.61%
- Pretax Margin
- 9.61%
- Net Profit Margin
- 5.93%
- EBITDA Margin
- 58.57%
- EBIT Margin
- 29.65%
Analyst Forecast
The average price target for Collegium Pharmaceutical is EUR 43.61, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 43.61
- Price Target Upside
- 107.65% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 7
- Revenue Growth Forecast
- 6.56%
- EPS Growth Forecast
- 25.86%
Scores
- Smart Score
- 10
- AI Score
- ―